Covidien Releases Clinical Trial Results Supporting the Use of Endoscopic Ablation Therapy as Barrett’s Esophagus Treatment

Covidien, Mansfield, Mass.-based healthcare products company, has announced the results of a clinical trial designed to test the efficacy of its Barrx RF Ablation System as a Barrett’s esophagus treatment.

Advertisement
Carrie Pallardy

The randomized, prospective, multicenter, controlled trial involved 136 Barrett’s esophagus patients with low-grade dysplasia. After the last endoscopy visit, 90 percent of the patients treated with ablation demonstrated no signs of Barrett’s esophagus tissue.

More Articles on Gastroenterology:
8 Trends Shaping the Present & Future of Gastroenterology
PENTAX Launches Video Processor With PENTAX i-SCAN
Vision-Sciences Names Howard Zauberman Interim CEO

CDI + AI at Cape Fear: An integrated blueprint for clinical excellence and revenue integrity

Recommended Live Webinar on Mar 24, 2026 1:00 PM - 2:00 PM CST

Advertisement

Next Up in GI & Endoscopy

  • Which GIs get paid the most?

    General gastroenterologists earn an average base salary of $526,273 — more than $218,000 higher than their pediatric counterparts, who report…

    By: Patsy Newitt

  • MUSC launches advanced endoscopy program

    The MUSC Shawn Jenkins Children’s Hospital in Charleston, S.C., has launched the MUSC Advanced Pediatric Endoscopy Program and Pancreas Center. …

    By: Cameron Cortigiano
Advertisement

Comments are closed.